Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry
2018 ◽
Vol 9
(2)
◽
2014 ◽
Vol 30
(3)
◽
pp. 334-344
2016 ◽
Vol 1035
◽
pp. 76-83
◽
2015 ◽
Vol 38
(17)
◽
pp. 1585-1592
◽
2012 ◽
Vol 61
◽
pp. 86-92
◽
2013 ◽
Vol 5
(4)
◽
pp. 31-36
2018 ◽
Vol 35
(12)
◽
pp. 2387-2399
◽